Literature DB >> 30595075

Successful in vitro maturation for urgent fertility preservation despite hormonal contraception by continuous progestin application.

Sabine Roesner1, Stephanie Hecht1, Ariane Germeyer1, Thomas Strowitzki1.   

Abstract

We report a unique case of a rare utilization of IVM. This case shows the successful retrieval of immature oocytes followed by in vitro maturation (IVM) for fertility preservation in a patient undergoing chronic progestin contraception. A 24-year-old patient with anaplastic astrocytoma requiring chemotherapy with temozolomide for 12 cycles as soon as possible with wish for fertility preservation while using a long acting etonogestrel birth control implant presented in our unit for fertility preservation in May 2017. The currently used implant should be preserved for further contraception. As the ovaries presented with a high, pco-like, antral follicle count, IVM was offered; the patient agreed. A transvaginal follicular puncture in general anesthesia without any hormonal intervention and IVM of gained oocytes was performed. As the patient actually had no spouse, she decided to freeze unfertilized metaphase II stage oocytes (MII). Thirteen oocytes were obtained, eight of them could be matured and cryopreserved. IVM could be a possibility for fertility preservation in patients with polycystic ovaries when no time is available for stimulation for conventional in vitro fertilization. Even use of continuous progestin application for contraception is no obstacle.

Entities:  

Keywords:  maturation; Fertility preservation; contraception; progestin

Mesh:

Substances:

Year:  2018        PMID: 30595075     DOI: 10.1080/09513590.2018.1531985

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  1 in total

1.  Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.

Authors:  P Rodrigues; M Marques; S Pimentel; M Rato; P Carvalho; S C Correia; N Mendes; H Amaral; J P Fernandes; M J Carvalho; C E Plancha
Journal:  J Assist Reprod Genet       Date:  2020-10-28       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.